Tools chosen: kalshi_direct kalshi_related polymarket_related claude_news congress_bills gdelt_news wikipedia

Sub-questions (Fermi decomposition)

Planner reasoning

This hinges on the hemp THC provision in the FY2026 agriculture appropriations act (signed Nov 12, 2025), which redefines hemp to cap total THC at ~0.4 mg per container with a one-year delayed effective date landing around Nov 12, 2026 — just before the Nov 16, 2026 resolution date. So 'Yes' requires Congress (or courts/agencies) to repeal, delay, or amend that provision, or a legal interpretation preserving 3mg beverages. Research should anchor on the Kalshi price and then assess legislative momentum for a fix (e.g., Paul/Wyden amendments, FY2027 approps) and any litigation or FDA/USDA guidance.

# Current state The federal effective date for the 0.4 mg-per-container THC cap (Section 781, P.L. 119-37) is November 12, 2026 — before the Nov 16, 2026 resolution date — meaning a 3 mg delta-9 THC beverage would be unlawful under the CSA unless Congress delays/repeals the provision first. The Senate passed a one-month delay (to Dec. 11, 2026) on Aug 8, 2026, but as of the latest research (late Aug 2026) the House had not yet acted, and government-funding deadlines (Sept 30) were the forcing event for House action. No FDA guidance has been issued despite a Feb 10, 2026 statutory deadline. # Timeline of key events - 2025-11-12: President Trump signs P.L. 119-37 (H.R. 5371), including Section 781 redefining hemp with a 0.4 mg/container total THC cap. (confirmed) - 2026-02-10: Statutory deadline for FDA to issue cannabinoid list/container guidance — missed; FDA has published nothing. (confirmed) - 2026-05: Hemp Planting Predictability Act (Baird) sits in subcommittee; slowly gains cosponsors (39 bipartisan by late July). (reported) - 2026-07-31: Texas state-level THC ban takes effect (separate from federal issue, illustrates political momentum against hemp THC products). (confirmed) - 2026-08-06: Senate Ag Committee markup of Farm Bill fails 10-11; no hemp amendment adopted; Boozman recesses committee indefinitely. (reported) - 2026-08-08: Senate passes H.R. 6500 (CR to Dec 11, 2026) 90-6, including a one-month delay of the natural-hemp THC ban (to Dec 11, 2026); tables Budd amendment to strip the delay, 61-32. Synthetic cannabinoids still banned Nov 12 regardless. (confirmed per multiple outlets) - 2026-08-10: Texas federal judge rejects emergency motion against state THC ban (state-level, contextual). (confirmed) - Late Aug 2026: House has not acted on the Senate delay; must act before Sept 30 funding deadline for delay to take effect; White House/OMB and HHS (Oz) reportedly support delay; 35 state AGs and Sen. Budd-led group oppose it. (reported) # Event Will a 12-oz hemp-derived beverage containing exactly 3 mg naturally-produced delta-9 THC (no other cannabinoids) be federally lawful to sell as of end-of-day Nov 16, 2026? # Outcomes to forecast - Yes (federally lawful to sell) - No (federally unlawful) # Kalshi market anchor Current YES price: **26%** (single data point; 7-day and 30-day change: 0.00%, i.e., flat/stale). Average daily volume ~1,394 contracts. No price history range beyond the single 26% reading — market has not moved recently in available data, suggesting either thin recent trading or a plateau after the Aug 8 Senate vote. This 26% is the consensus to beat. # Sub-question answers 1. **Effective date of redefinition** — Section 781 of P.L. 119-37 (signed Nov 12, 2025) takes effect Nov 12, 2026, which is before the Nov 16, 2026 resolution date. [claude_news/multiple] 2. **Does 0.4 mg cap make 3 mg beverage unlawful?** — Yes; the new rule caps total THC at 0.4 mg per container regardless of size, so a 3 mg beverage exceeds the cap ~7.5x and would lose "hemp" status, falling under CSA marijuana rules once in force. [csgsouth.org via claude_news] 3. **Active legislation to repeal/delay** — Senate passed a delay to Dec 11, 2026 (H.R. 6500, Aug 8, 2026, 90-6); House had not acted as of late Aug 2026. Standalone repeal/delay bills (Mace's American Hemp Protection Act, Baird's Hemp Planting Predictability Act, Barr/Craig's Lawful Hemp Protection Act) remain stalled in committee; Senate Farm Bill markup failed Aug 6, 2026. [claude_news, congress_bills] 4. **Pending lawsuits/injunctions** — No federal lawsuit/injunction against Section 781 identified in research (Texas litigation found is state-law-specific, unrelated to federal Section 781). [gdelt_news] 5. **FDA/USDA/DEA guidance or enforcement discretion** — FDA missed its Feb 10, 2026 statutory deadline to issue cannabinoid list/container definitions and has issued nothing; no enforcement-discretion signals found in research. [hazeconnect via claude_news] 6. **Kalshi price history** — Only single data point (26%), flat 7d/30d change; no adjacent-date series data found (kalshi_related returned 0 matches). [kalshi_direct] # Key facts (high-confidence, factual) 1. [claude_news/congress.gov] P.L. 119-37 Section 781 sets a 0.4 mg total THC/container cap, effective Nov 12, 2026. 2. [claude_news] Senate passed a delay to Dec 11, 2026 on Aug 8, 2026 (90-6); requires House concurrence + presidential signature to take effect. 3. [claude_news] House had not acted as of late Aug 2026; Sept 30 funding deadline was the key forcing event. 4. [claude_news] FDA guidance mandated by Feb 10, 2026 is overdue/unpublished. 5. [claude_news] 35 state AGs and Sen. Budd bloc oppose delay; White House/OMB/HHS reportedly support it. # Cross-market signals - Kalshi related: none found (0 markets in series/keyword scan). - Polymarket: no matching markets found. - Sportsbook implied: N/A (not a sports market). # Analyst opinions and speculation - Hemp Law Group (late Aug 2026): "Until the House approves it and the President signs it, November 12 stands" — implying default outcome is ban takes effect absent further action. - Multiple trade press frame this as a live legislative fight with uncertain House timeline; no consensus on House passage odds found. # Directional lean per outcome - **Yes** (legal): Senate-passed delay, White House/HHS support, bipartisan cosponsor growth on House bills suggest some path to delay/repeal before Nov 16, 2026, but requires House action + Sept 30 deadline pressure to materialize into law before the effective date. - **No** (illegal): Statutory default (Nov 12, 2026 effective date) is already law; House inaction as of late Aug 2026, failed Senate Farm Bill markup, and AG opposition suggest delay may stall; even if Dec 11 delay passes, that only pushes ban past Nov 16 — but would still make outcome "Yes" if enacted before Nov 12/16. Absent House action, default is "No." # Gaps / unknowns - No data on House action after Aug 22, 2026 (research cutoff); critical for resolution given Sept 30 funding deadline and Nov 12 effective date are both before Nov 16, 2026. - No confirmation whether Senate's Dec 11 delay, if only passed by House later, would apply retroactively or in time. - No litigation/injunction data found closer to Nov 2026. - Kalshi price series is essentially a single snapshot; can't assess momentum reliably. # Calibration anchors - Kalshi current YES price (anchor): 26%. - Precedent: Farm Bill/hemp regulatory fights historically resolve via last-minute CR riders (2018 Farm Bill signed Dec 20 after Dec 11-12 votes) — suggests late/near-deadline legislative action is plausible but outcome uncertain.

1. Both forecasts converge almost exactly on the stale 26% Kalshi anchor (26% and 29%), despite Forecast 2's own point that "the delay is attached to must-pass funding legislation and has unusually strong Senate support" — neither explains why this shouldn't move the estimate more, especially given the 2018 Farm Bill precedent cited in the brief of last-minute CR-rider passage of hemp provisions. 2. Neither forecast addresses the timing/retroactivity ambiguity flagged in the brief: "No confirmation whether Senate's Dec 11 delay, if only passed by House later, would apply retroactively or in time" — if the House passes the delay after Nov 12 but before Nov 16, it's unclear whether this resolves Yes, and neither rationale grapples with this edge case explicitly. 3. Both treat House action as a binary "acts by Sept 30 CR or default No," but the brief's gap note says data cuts off after Aug 22 — neither forecast considers alternate legislative vehicles (a second CR, omnibus, or standalone bill passing in October before Nov 12) that could still deliver a delay outside the original Sept 30 forcing event. 4. The confidence scores (0.44 vs 0.59) are inconsistent with how similar the two probability distributions and rationales are — Forecast 2 claims meaningfully higher confidence despite reaching essentially the same conclusion and citing the same unresolved House hurdle, which is not well justified. 5. Neither forecast considers whether "federally legal to sell" might hinge on enforcement discretion/practical availability rather than strict statutory status — given "FDA has issued nothing" and no enforcement-discretion signal was found, there's ambiguity about how the market would resolve if the law is technically in effect but unenforced, which could shift probability mass either direction. 6. Both forecasts almost entirely omit the political-opposition side (35 state AGs, Sen. Budd bloc, Rep. Andy Harris) as a live risk that could sink even a House-passed delay in conference or via presidential veto threat — this is mentioned but not weighted as a distinct negative scenario beyond "House inaction."

29% (52% confidence)

Yes: 29% No: 71%

The statutory default dominates: Section 781's 0.4 mg/container cap takes effect Nov 12, 2026, four days before resolution, making a 3 mg beverage unlawful absent enacted relief — and no litigation, injunction, or FDA enforcement-discretion signal exists to soften it. The credible path to Yes runs through the Senate's 90-6 delay to Dec 11 riding on must-pass funding legislation with reported White House/HHS support, and the critique is right that a must-pass vehicle plus possible October vehicles (second CR, omnibus) gives more than one bite at the apple, justifying a nudge above the stale 26% anchor. Offsetting that, Rep. Harris (author of the original ban and an appropriations gatekeeper), 35 state AGs, and the Budd bloc are entrenched, House inaction persisted through the research cutoff, standalone bills are stalled, and the Senate Farm Bill markup failed. Retroactivity ambiguity (House passage between Nov 12 and Nov 16) is a narrow edge case that adds little mass and could cut either way on resolution. Net: a small upward adjustment from the market to 29% Yes.

Total pipeline time: 229.8s